Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Reduced Diphosphopyridine Nucleotide Synergism of the Reduced Triphosphopyridine Nucleotide-Dependent Mixed-Function Oxidase System of Hepatic Microsomes

I. Effects of Activation and Inhibition of the Fatty Acyl Coenzyme A Desaturation System

MARIA ALMIRA CORREIA and G. J. MANNERING
Molecular Pharmacology July 1973, 9 (4) 455-469;
MARIA ALMIRA CORREIA
Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. J. MANNERING
Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Time first of the 2 electrons required for the N-demethylation of ethylmorphine by the microsomal mixed-function oxidase system of liver is thought to be donated by TPNH, whereas the second has been postulated to be derivable from either TPNH or DPNH and transported to the cytochrome P-450 system via cytochrome b5. DPNH is believed to support a larger pool of second electrons at cytochrome b5 than can be supplied by TPNH, and this would explain the synergistic effect of DPNH on TPNH-dependent mixed-function oxidase reactions. This concept was strengthened by the current studies, which altered the pool of second electrons at cytochrome b5 by manipulating the shunt of electrons from cytochrome b5 to the microsomal fatty acyl-CoA desaturation system. When the activity of this shunt was inhibited with cyanide, DPNH synergism of ethylmorphine N-demethylation was increased from 30% (no cyanide) to 90% (0.1 or 0.5 mM cyanide). Cyanide had little or no effect on N-demethylation when TPNH was the sole source of electrons. When the activity of the desaturation system was stimulated by the addition of stearoyl-CoA, a natural substrate for the system, rates of N-demethylation declined when TPNH was the sole donor of electrons and when both TPNH and DPNH were present. Cyanide reversed the inhibitory effect of stearoyl-CoA. These results are interpreted to mean that second electrons, which are normally transported from DPNH through cytochrome b5 to the cytochrome P-450 system, are dissipated in large part via cyanide-sensitive systems engaged in the oxidation of endogenous substrates; cyanide largely prevents this dissipation of second electrons, more of the electron pool at cytochrome b5 is made available to the cytochrome P-450 system, and DPNH synergism is enhanced. Cyanide is without effect on the cytochrome P-450 system when TPNH is the sole source of electrons, because the steady-state concentration of reduced cytochrome b5 that can be maintained by TPNH is below the level where a serious loss of electrons to endogenous systems via cytochrome b5 can occur. Stearoyl-CoA increases the dissipation of electrons by serving as a substrate for the cyanide-sensitive desaturation system. It is postulated that stearoyl-CoA inhibits ethylmorphine N-demethylation because the desaturation system and the mixed-function oxidase system compete for electrons supplied by an unidentified electron transfer component, which accepts electrons from either DPNH or TPNH via cytochrome b5. These concepts were reinforced by studies in which rates of DPNH utilization were correlated with rates of ethylmorphine N-demethylation.

ACKNOWLEDGMENT The authors gratefully acknowledge the able technical assistance of Miss Virginia Kickertz.

  • Copyright ©, 1973, by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 9, Issue 4
1 Jul 1973
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Reduced Diphosphopyridine Nucleotide Synergism of the Reduced Triphosphopyridine Nucleotide-Dependent Mixed-Function Oxidase System of Hepatic Microsomes
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Reduced Diphosphopyridine Nucleotide Synergism of the Reduced Triphosphopyridine Nucleotide-Dependent Mixed-Function Oxidase System of Hepatic Microsomes

MARIA ALMIRA CORREIA and G. J. MANNERING
Molecular Pharmacology July 1, 1973, 9 (4) 455-469;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Reduced Diphosphopyridine Nucleotide Synergism of the Reduced Triphosphopyridine Nucleotide-Dependent Mixed-Function Oxidase System of Hepatic Microsomes

MARIA ALMIRA CORREIA and G. J. MANNERING
Molecular Pharmacology July 1, 1973, 9 (4) 455-469;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antimicrobial and Antileukemic Transportan 10 Conjugates
  • Pharmacological characterization of zebrafish H1 receptor
  • Bhave and Forman
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics